Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety

Clinical trial NCT02883374 · UNKNOWN

Trial details

NCT number: NCT02883374
Sponsor: Dong mei
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocystic Carcinoma

Start date: 2016-11-01
Primary completion: 2020-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.